Molecular and prognostic markers in prostate cancer. A study of cell-cycle regulators, angiogenesis and candidate markers.
Halvorsen
Ole Johan
OJ
The Gade Institute, Section for Pathology, University of Bergen, Bergen, Norway.
D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000032:analysis / Q000378:metabolism*; D018797:Cell Cycle Proteins / Q000032:analysis* / Q000378:metabolism*; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000032:analysis / Q000378:metabolism; D003937:Diagnosis, Differential; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis / Q000378:metabolism; D008297:Male; D009389:Neovascularization, Pathologic / Q000175:diagnosis*; D051059:PTEN Phosphohydrolase / Q000378:metabolism; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis / Q000378:metabolism; D011467:Prostate / Q000098:blood supply / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000098:blood supply / Q000175:diagnosis / Q000628:therapy
D051792:Basic Helix-Loop-Helix Proteins; D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D019394:Ki-67 Antigen; D051059:PTEN Phosphohydrolase; D018809:Proliferating Cell Nuclear Antigen; D017430:Prostate-Specific Antigen; C417032:SIM2 protein, human; C413374:p27 antigen